Allogene Therapeutics, Inc. (ALLO) Tops Q3 EPS by 1c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• AAR To Pay $1.8B For Stake In Aircraft-maintenance Company - WSJ
• Franco-Nevada Announces Appointment of Paul Brink as Chair of the World Gold Council
• Chipotle Mexican Grill (CMG) call put ratio 9.5 calls 1 put with a focus on October 34 and January 40 calls as share price up 4%